• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[罗红霉素对医院细菌的体外活性及协同曲线]

[In vitro activity of roxithromycin against hospital bacteria and the concordance curve].

作者信息

Soussy C J, Chanal M, Kitzis M D, Duval J, Cluzel R, Acar J F

机构信息

Service de Bactériologie, CHU Henri-Mondor, Creteil.

出版信息

Pathol Biol (Paris). 1988 May;36(5):420-4.

PMID:2900488
Abstract

This study was set up to establish the regression curve for roxithromycin inhibition zone diameters (disks 15 micrograms) and MIC to create a strain distribution plot, in order to allow accurate interpretation of the disk diffusion method for testing susceptibility to roxithromycin. 373 bacterial strains were studied in three university hospital. Roxithromycin was active against erythromycin sensitive Staphylococcus aureus and coagulase negative Staphylococci at concentrations of 0.06 to 4 micrograms/ml (mode 0.5). Erythromycin resistant strains were also resistant to roxithromycin. Enterococci could be divided into two populations, one resistant (MIC greater than 128 micrograms/ml) and the other with MIC of 0.5 to 32 (mode 1-2). This was also the case for Streptococci and Pneumococci with MIC lower for susceptible strains (mode 0.06-0.12). Roxithromycin was active on Haemophilus at concentrations of 0.12 to 32 micrograms/ml; MIC for beta-lactamase producing strains were comparable to those of strains not producing. MIC for Gonococci were low (less than 0.008 to 0.12), except for three strains. They were higher for Meningococci (0.03 to 32) with a majority of strains inhibited by 0.5 to 4 micrograms/ml. MIC were 4 for Clostridium perfringens; Bacteroides fragilis strains were inhibited by 0.5 to 2 micrograms/ml. The correlation coefficient for regression curve was 0.79; for critical concentrations less than or equal to 1 and greater than 4 micrograms/ml, critical diameters are greater than or equal to 22 and less than 17 mm.

摘要

本研究旨在建立罗红霉素抑菌圈直径(15微克纸片)与最低抑菌浓度(MIC)的回归曲线,以绘制菌株分布图,从而能够准确解释用于检测对罗红霉素敏感性的纸片扩散法。在三家大学医院对373株细菌进行了研究。罗红霉素对红霉素敏感的金黄色葡萄球菌和凝固酶阴性葡萄球菌的活性浓度为0.06至4微克/毫升(众数为0.5)。红霉素耐药菌株对罗红霉素也耐药。肠球菌可分为两个群体,一个耐药(MIC大于128微克/毫升),另一个群体的MIC为0.5至32(众数为1 - 2)。链球菌和肺炎球菌也是如此,敏感菌株的MIC较低(众数为0.06 - 0.12)。罗红霉素对嗜血杆菌的活性浓度为0.12至32微克/毫升;产β-内酰胺酶菌株的MIC与不产酶菌株相当。淋球菌的MIC较低(小于0.008至0.12),但有三株除外。脑膜炎球菌的MIC较高(0.03至32),大多数菌株在0.5至4微克/毫升时受到抑制。产气荚膜梭菌的MIC为4;脆弱拟杆菌菌株在0.5至2微克/毫升时受到抑制。回归曲线的相关系数为0.79;对于临界浓度小于或等于1微克/毫升和大于4微克/毫升,临界直径分别大于或等于22毫米和小于17毫米。

相似文献

1
[In vitro activity of roxithromycin against hospital bacteria and the concordance curve].[罗红霉素对医院细菌的体外活性及协同曲线]
Pathol Biol (Paris). 1988 May;36(5):420-4.
2
[In vitro antibacterial activity of clarithromycin, a new macrolide antibiotic, and regression curve].新型大环内酯类抗生素克拉霉素的体外抗菌活性及回归曲线
Pathol Biol (Paris). 1990 May;38(5):401-6.
3
[In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study].[头孢曲松对医院细菌的体外活性。一项多中心研究的结果]
Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):469-72.
4
[Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].亚胺培南(N-甲酰亚胺基硫霉素)对医院细菌体外作用的多中心研究
Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):487-92.
5
The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.罗红霉素(RU 28965)与四种口服抗生素的体外活性比较。
Drugs Exp Clin Res. 1987;13(4):201-3.
6
[In vitro antibacterial activity of apalcillin on aerobic bacteria and the regression curve].阿洛西林对需氧菌的体外抗菌活性及回归曲线
Pathol Biol (Paris). 1988 Jun;36(5 Pt 2):660-4.
7
The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.新型大环内酯类抗生素罗红霉素与红霉素的体外活性比较。
Drugs Exp Clin Res. 1987;13(9):563-6.
8
[In vitro antibacterial activity of a new macrolide, miokamycin. Results of a multicenter study].[一种新型大环内酯类抗生素——米卡霉素的体外抗菌活性。一项多中心研究的结果]
Pathol Biol (Paris). 1989 May;37(5):358-63.
9
[In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].新型半合成大环内酯类药物罗红霉素对专性厌氧菌的体外活性
Pathol Biol (Paris). 1986 May;34(5):440-4.
10
[In vitro activity of ceftizoxime on hospital bacteria. Results of a multicenter study].[头孢唑肟对医院细菌的体外活性。一项多中心研究的结果]
Pathol Biol (Paris). 1984 May;32(5):326-30.

引用本文的文献

1
Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use.罗红霉素。其抗菌活性、药代动力学特性及治疗用途的最新进展。
Drugs. 1994 Aug;48(2):297-326. doi: 10.2165/00003495-199448020-00011.